Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ychou

Showing results (11-20 of 103) with videos related to

Pageof 11
Sort By:
Anticancer Research|June 9, 2001
5-fluorouracil and leucovorin as second-line chemotherapy in carcinomas of unknown primary siteS Culine, M Ychou, M Fabbro, et al.
Disease Markers|May 31, 2001
Clinical significance and prognostic value of CA72-4 compared with CEA and CA19-9 in patients with gastric cancerM Ychou, J Duffour, A Kramar, et al.
Revue D'Epidemiologie Et De Sante Publique|October 16, 1999
[Generalized ROC criteria in the evaluation of several tumor markers]A Kramar, D Faraggi, M Ychou, et al.
Annales De Gastroenterologie Et D'Hepatologie|November 1, 1991
[Severe ischemic hepatitis after taking cibenzoline]J Gutknecht, D Larrey, M Ychou, et al.
Zentralblatt Fur Veterinarmedizin. Reihe A|February 1, 1985
Differences in coagulability of three glutaraldehyde solutions in the glutaraldehyde test on bovine whole bloodL Mahin, M Chadli, A Marzou, et al.
Bulletin Du Cancer|November 20, 2001
[A comparison of serum Cyfra 21-1 and SCC AG in the diagnosis of squamous cell esophageal carcinoma]M Ychou, F Khemissa-Akouz, A Kramar, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|February 18, 2003
[Chemoradiotherapy in the adjuvant treatment of gastric adenocarcinomas: real progress?]L Mineur, F Lacaine, M Ychou, et al.
Bulletin Du Cancer|March 9, 2006
[Recommendations for clinical practice: management of stomach adenocarcinoma]M Ychou, O Bouché, F Marchal, et al.
Gastroenterologie Clinique Et Biologique|March 15, 2003
[Therapeutic management of hepatic metastases from colorectal cancers]F Lazorthes, F Navarro, M Ychou, et al.
Gastroenterologie Clinique Et Biologique|October 24, 2008
[Efficacy of prolonged-release somatostatin analog monotherapy in metastatic endocrine tumors]J-M Kanyinda-K, E Samalin, H Sebah, et al.
Pageof 11

Showing results (11-20 of 103) with videos related to

Sort By:
Pageof 11
Anticancer Research|June 9, 2001
5-fluorouracil and leucovorin as second-line chemotherapy in carcinomas of unknown primary siteS Culine, M Ychou, M Fabbro, et al.
Disease Markers|May 31, 2001
Clinical significance and prognostic value of CA72-4 compared with CEA and CA19-9 in patients with gastric cancerM Ychou, J Duffour, A Kramar, et al.
Revue D'Epidemiologie Et De Sante Publique|October 16, 1999
[Generalized ROC criteria in the evaluation of several tumor markers]A Kramar, D Faraggi, M Ychou, et al.
Annales De Gastroenterologie Et D'Hepatologie|November 1, 1991
[Severe ischemic hepatitis after taking cibenzoline]J Gutknecht, D Larrey, M Ychou, et al.
Zentralblatt Fur Veterinarmedizin. Reihe A|February 1, 1985
Differences in coagulability of three glutaraldehyde solutions in the glutaraldehyde test on bovine whole bloodL Mahin, M Chadli, A Marzou, et al.
Bulletin Du Cancer|November 20, 2001
[A comparison of serum Cyfra 21-1 and SCC AG in the diagnosis of squamous cell esophageal carcinoma]M Ychou, F Khemissa-Akouz, A Kramar, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|February 18, 2003
[Chemoradiotherapy in the adjuvant treatment of gastric adenocarcinomas: real progress?]L Mineur, F Lacaine, M Ychou, et al.
Bulletin Du Cancer|March 9, 2006
[Recommendations for clinical practice: management of stomach adenocarcinoma]M Ychou, O Bouché, F Marchal, et al.
Gastroenterologie Clinique Et Biologique|March 15, 2003
[Therapeutic management of hepatic metastases from colorectal cancers]F Lazorthes, F Navarro, M Ychou, et al.
Gastroenterologie Clinique Et Biologique|October 24, 2008
[Efficacy of prolonged-release somatostatin analog monotherapy in metastatic endocrine tumors]J-M Kanyinda-K, E Samalin, H Sebah, et al.
Pageof 11